BEAMTREE HOLDINGS LIMITED — Capital/Financing Update 2021

Mar 25, 2021

==> picture [135 x 52] intentionally omitted <==

ASX Announcement

PKS Holdings Limited (ASX: PKS)

Sydney, 26 March 2021

Successful Completion of Share Purchase Plan

The Board of PKS Holdings Limited (ASX: PKS) (“PKS” or the “Company”), advises that it has successfully completed its Share Purchase Plan (SPP) which was announced on 23 February 2021, raising $1,000,000.

A total of 2,857,143 new fully paid shares are expected to be issued.

The SPP was strongly supported with 159 shareholders participating. PKS has exercised its discretion to scale back applications.

The shares will be issued to successful applicants at A$0.35 Per share, being the same as the Placement Price advised to the ASX on 23 February 2021 and rank equally with existing PKS fully paid ordinary shares.

The Company wishes to thank its existing shareholders for their ongoing support and their participation in the SPP.

This announcement has been authorised by the Chair.

-END-

For further information please contact:

Tim Kelsey Mike Hill CEO PKS Holdings Chairman, PKS Holdings Phone: 0476 835 311 Phone: 0421 056 691

About PKS

PKS is an Australian Healthcare company that works with health organisations around the world to better capture, manage and leverage their human expertise to improve the performance of their business and deliver better patient outcomes. PKS’ products have a broad range of applications across the healthcare services industry. The key value propositions of the PKS’ suite of software applications focus on and have the potential to:

• Clinical Decision Support, which enables better decision making, leading to improved patient outcomes and a reduction in medical errors;

• Improve operational efficiency, with opportunities for significant cost savings and revenue improvements;

• Improve the quality of data, which makes the billing processes in healthcare organisations more accurate and more efficient; and

1

• Leverage off data analytics and benchmarking, which provides insights into healthcare data and enables healthcare organisations to improve the quality of patient care.

With the recent acquisition of Pavilion Health, the suite of software products now consists of:

• RippleDown® enables any clinical domain expert – typically a pathologist or clinician – to automate their unique, human decision-making process at scale in order to provide real-time clinical analysis, interpretations and treatment recommendations. By aggregating and analysing all available patient information – including current and historical results – RippleDown® is able to provide a holistic view of patients to generate the most comprehensive and patient-specific interpretations and recommendations.

• RippleDown® is managed by domain experts, not IT, enabling rules to be built quickly and easily to ensure the system remains updated and relevant.

• PICQ® is an auditing tool used in hospitals that assesses every record clinically coded for data quality. It measures data accuracy against indicators and identifies records for correction and uses a set of pre-determined indicators created and maintained by PKS’ subject-matter experts to identify records that may be incorrectly coded.

• RISQ[TM] Reviews records in datasets to assess the quality of Condition Onset Flags (COF) data and incidences of hospital-acquired complications (HACs). It provides a method to benchmark hospitals against statistical peers to provide industry benchmarks of HAC incidence and underlying data quality.

• Codexpert[TM] is a web-based eBook application providing the full health-data classification reference for clinical coding of patient episodes.

2